Let’s start up with the current stock price of Capricor Therapeutics Inc. (CAPR), which is $4.99 to be very precise. The Stock rose vividly during the last session to $4.82 after opening rate of $4.36 while the lowest price it went was recorded $4.36 before closing at $4.39.
Recently in News on January 12, 2021, Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications. —Capricor to leverage Lonza’s expertise in technology transfer and development of cellular therapies to take CAP-1002 through potential product launch and commercial supply—. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Capricor Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.96 on 01/12/21, with the lowest value was $3.32 for the same time period, recorded on 01/04/21.
Capricor Therapeutics Inc. (CAPR) full year performance was 162.87%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Capricor Therapeutics Inc. shares are logging -59.52% during the 52-week period from high price, and 466.70% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.88 and $12.32.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 7548269 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Capricor Therapeutics Inc. (CAPR) recorded performance in the market was 27.99%, having the revenues showcasing -10.95% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 82.14M, as it employees total of 16 workers.
The Analysts eye on Capricor Therapeutics Inc. (CAPR)
During the last month, 0 analysts gave the Capricor Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.59, with a change in the price was noted -1.20. In a similar fashion, Capricor Therapeutics Inc. posted a movement of -19.42% for the period of last 100 days, recording 836,508 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CAPR is recording 0.12 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.12.
Technical rundown of Capricor Therapeutics Inc. (CAPR)
Raw Stochastic average of Capricor Therapeutics Inc. in the period of last 50 days is set at 62.88%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 62.88%. In the last 20 days, the company’s Stochastic %K was 67.63% and its Stochastic %D was recorded 61.24%.
Considering, the past performance of Capricor Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 27.99%. Additionally, trading for the stock in the period of the last six months notably improved by 7.60%, alongside a boost of 162.87% for the period of the last 12 months. The shares increased approximately by 17.38% in the 7-day charts and went up by 5.78% in the period of the last 30 days. Common stock shares were lifted by -10.95% during last recorded quarter.